CClinicalTrials.gg
CompletedNCT00266084Updated May 11, 2016

Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix

An observational study in Uterine Cervical Dysplasia, Uterine Cervical Intraepithelial Neoplasia and Uterine Cervical Neoplasia, sponsored by University Hospitals Cleveland Medical Center. Completed. Open to female participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2016-05-11.

Sponsored by University Hospitals Cleveland Medical Center · Observational

Study type
Observational
Enrollment
85
Ages
14 Years and older
Sex
Female
01

Study summary

This study tested the safety and performance of a new cell collector device and compared the results to those obtained with the current existing device that are being used routinely

Read the detailed description

This study tested the feasibility, safety and efficacy of the new e2TM Collector, and compared its performance with the standard method for obtaining cervical cells for Pap test of endocervical cytobrush and Ayer's Spatula

02

Conditions studied

  • Uterine Cervical Dysplasia
  • Uterine Cervical Intraepithelial Neoplasia
  • Uterine Cervical Neoplasia
  • Uterine Cervical Cancer

Keywords

  • Cervix
  • Uterus
  • Dysplasia
  • Cancer
  • Collector
03

In context

Uterine Cervical Neoplasms

1,881 studies on the registry are indexed under Uterine Cervical Neoplasms; 567 are open to participants now.

This study's enrollment of 85 is below the median of 220 across 419 observational studies indexed under Uterine Cervical Neoplasms.

Browse Uterine Cervical Neoplasms studies →

Lead sponsor

University Hospitals Cleveland Medical Center is the lead sponsor of 283 studies on the registry; 42 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 29 (91%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

Women ages >14 being followed for a previous abnormal Pap All patients will have signed an Informed Consent form prior to being enrolled in this study

Exclusion criteria

Exclusion Criteria:

Patients who have had a hysterectomy

05

Study design

Enrollment
85 participants
06

Study locations

No study locations are listed for this record.

07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00266084
Lead sponsor
University Hospitals Cleveland Medical Center
First posted
Dec 15, 2005
Start date
Aug 1999
Completion
Nov 2001
Last update
May 11, 2016

Study contacts

George I Gorodeski, MD PhD
principal investigator · University Hospitals of Cleveland, Case Western Reserve University
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2001. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion